retatrutide and high blood pressure Side Effects: What Patients Should Know Retatrutide Side Effects Guide: 21

It is not available as a licensed medicine through the NHS, and it is not listed in the British National Formulary (BNF)

There are numerous ongoing studies investigating protein metabolism in the hope that these studies may inform preventative medicine and dietary change guidance in the future to support healthy ageing

Retatrutide is primarily metabolized through peptide hydrolysis and beta-oxidation of its fatty acid component

Lipodystrophy Administration of insulin subcutaneously, including insulin glargine products, has resulted in lipoatrophy (depression in the skin) or lipohypertrophy (enlargement or thickening of tissue) in some patients [see DOSAGE AND ADMINISTRATION ]